Breast Cancer :: Role of folate unclear in breast cancer risk
There’s no clear relationship between folate intake or blood folate levels and breast cancer risk, a new study suggests.
Breast cancer
Breast Cancer :: Housework cuts breast cancer risk
Women who exercise by doing housework can reduce their risk of breast cancer, according to a new study. The research is published in the journal Cancer Epidemiology Biomarkers and Prevention.
Breast Cancer :: Glaxo’s Tykerb drug delays spread of breast cancer
GlaxoSmithKline’s new drug Tykerb dramatically slows the spread of aggressive late-stage breast cancer. Data from a Phase III study reporting that Tykerb? (lapatinib) plus Xeloda? (capecitabine) is superior to capecitabine alone in women with HER2 (ErbB2) positive advanced breast cancer who had progressed following prior therapy, including Herceptin? (trastuzumab), was published today in the New England Journal of Medicine (NEJM).
Breast Cancer :: Restoring tamoxifen sensitivity in resistant breast cancer cells
The widely used breast cancer drug tamoxifen (Nolvadex), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute, part of the National Institutes of Health, and their partners.
Breast Cancer :: Breast cancer stem cells resist radiation treatment
The population of breast cancer cells that gives rise to a tumor may be relatively resistant to radiotherapy and may even increase when given multiple treatments of radiation, a new study shows.
Breast Cancer :: Prior mammograms helps radiologists detect breast cancer
Viewing prior mammograms in association with current mammograms significantly improves radiologist performance and may decrease unnecessary recalls by up to 44 percent, according to a study in the January issue of Radiology.
Breast Cancer :: Women discontinue use of Aromatase Inhibitors
Breast Cancer Action (BCA) released a report today, in conjunction with a poster presentation at the San Antonio Breast Cancer Symposium, on the side effects of aromatase inhibitors (AIs). The report, “Side Effects Revealed: Women’s Experiences with Aromatase Inhibitors,” analyzes 612 women’s responses to an online survey of the drugs’ side effects.
Breast Cancer :: Breast cancer drop linked to decline in HRT
In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at The University of Texas M. D. Anderson Cancer Center.
Breast Cancer :: ARIMIDEX with HERCEPTIN Extended Survival in Breast Cancer
Data was presented today showing that postmenopausal women who received ARIMIDEX (anastrozole) and Herceptin (trastuzumab) in combination had a significant improvement in progression-free survival when treated for advanced breast cancer that was both human epidermal growth factor receptor-2 (HER-2)-positive and hormone receptor-positive.
Breast Cancer :: Breast cancer may put your marriage in danger
Married couples where breast cancer exists are in a risk situation when the cohesion level of the family is low, according to research carried out by the psychiatrist at the Family Diagnosis and Therapy Unit at the University Hospital of Navarra, Enrique Aub? Guedea.